DeepMed Research

ABIOMED, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1981-01-01

Employees: 2K

Market Cap: -

Website: http://www.abiomed.com

Clinical Trials

INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery (INTeGRATE)

Not Applicable

Not yet recruiting

Conditions: Heart Failure
Cardiogenic Shock
Reduced Ejection Fraction Heart Failure

First Posted Date: 2025-05-11

Last Posted Date: 2025-05-11

Lead Sponsor: Abiomed Inc.

Target Recruit Count: 60

Registration Number: NCT06965504

Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Not yet recruiting

Conditions: AMI Cardiogenic Shock

First Posted Date: 2025-05-09

Last Posted Date: 2025-05-09

Lead Sponsor: Abiomed Inc.

Target Recruit Count: 250

Registration Number: NCT06964685

Locations: 🇺🇸
St. Joseph Hospital Orange, Orange, California, United States
🇺🇸
Ascension via Christi, Wichita, Kansas, United States
🇺🇸
New Mexico Heart, Albuquerque, New Mexico, United States

Impella Pump Return Study to Analyze Deposits and Biomaterial in Used Pumps

Not yet recruiting

Conditions: Heart Failure

First Posted Date: 2025-03-25

Last Posted Date: 2025-03-25

Lead Sponsor: Abiomed Inc.

Target Recruit Count: 200

Registration Number: NCT06765226

Locations: 🇩🇪
Herzzentrum Dresden, Dresden, Saxony, Germany
🇩🇪
Deutsches Herzzentrum der Charité Berlin, Berlin, Germany

Impella RP Flex with Smart Assist

Recruiting

Conditions: Right Ventricular (RV) Dysfunction

First Posted Date: 2024-10-11

Last Posted Date: 2024-10-11

Lead Sponsor: Abiomed Inc.

Target Recruit Count: 200

Registration Number: NCT06637644

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Pima Heart and Vascular, Tucson, Arizona, United States
🇺🇸
Baptist Health Heart Failure and Transplant Institute, Little Rock, Arkansas, United States

and more 28 locations

Abiomed Impella RT-DAQ - Observational Study

Recruiting

Conditions: Cardiogenic Shock

First Posted Date: 2024-03-13

Last Posted Date: 2024-12-03

Lead Sponsor: Abiomed Inc.

Target Recruit Count: 125

Registration Number: NCT06308055

Locations: 🇨🇭
Universitätsspital Basel, Basel, Switzerland

Impella Real-World Surveillance of Patients Using Sodium Bicarbonate

Recruiting

Conditions: Cardiogenic Shock
High Risk PCI

First Posted Date: 2023-04-19

Last Posted Date: 2024-01-30

Lead Sponsor: Abiomed Inc.

Target Recruit Count: 330

Registration Number: NCT05820451

V-A ECMO AUTO Mode Registry

Recruiting

Conditions: Heart Failure

First Posted Date: 2023-03-08

Last Posted Date: 2024-12-03

Lead Sponsor: Abiomed Inc.

Target Recruit Count: 30

Registration Number: NCT05759377

Locations: 🇩🇪
UKGM Universtitätsklinikum Marburg, Marburg, Germany
🇩🇪
Brüderkrankenhaus Trier, Trier, Germany
🇩🇪
Uniklinik RWTH Aachen, Aachen, NRW, Germany

and more 3 locations

IMPACT EU Post-Market Clinical Follow-Up Study

Not Applicable

Recruiting

Conditions: Left Ventricular Dysfunction

First Posted Date: 2023-03-06

Last Posted Date: 2024-02-29

Lead Sponsor: Abiomed Inc.

Target Recruit Count: 123

Registration Number: NCT05756751

Locations: 🇨🇿
IKEM Prague, Prague, Czechia
🇩🇪
Universitätsklinikum Düsseldorf, Klinik für Herzchirurgie, Düsseldorf, NRW, Germany
🇩🇪
Universitätsklinikum Giessen, Giessen, Germany

and more 10 locations

IMpella-Protected cArdiaC Surgery Trial (IMPACT)

Not Applicable

Conditions: Left Ventricular Dysfunction

Interventions: Device: Impella 5.5 with SmartAssist

First Posted Date: 2022-09-07

Last Posted Date: 2025-05-07

Lead Sponsor: Abiomed Inc.

Target Recruit Count: 100

Registration Number: NCT05529654

Locations: 🇺🇸
Tri-City Medical Center, San Diego, California, United States
🇺🇸
University of Florida, Gainesville, Florida, United States
🇺🇸
NCH Rooney Heart Institute, Naples, Florida, United States

and more 20 locations

The RECOVER IV Trial

Not Applicable

Terminated

Conditions: ST-segment Elevation Myocardial Infarction (STEMI)
Cardiogenic Shock

Interventions: Other: Standard of Care
Device: Impella CP®

First Posted Date: 2022-08-18

Last Posted Date: 2025-01-29

Lead Sponsor: Abiomed Inc.

Target Recruit Count: 4

Registration Number: NCT05506449

Locations: 🇩🇪
Herzzentrum Dresden, Dresden, Saxony, Germany
🇨🇭
Inselspital Bern, Bern, Switzerland
🇩🇪
University Hospital Düsseldorf, Düsseldorf, Germany

and more 4 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy